Patents Assigned to NODUS THERAPEUTICS, INC.
  • Method of treating cancer with a multiple integrin binding Fc fusion protein
    Patent number: 10350266
    Abstract: The present invention provides a method of treating cancer with an integrin-binding-Fc fusion protein alone or in combination with IL-2 and/or an immune checkpoint inhibitor. The invention also provides composition for use in such methods.
    Type: Grant
    Filed: May 30, 2017
    Date of Patent: July 16, 2019
    Assignee: NODUS THERAPEUTICS, INC.
    Inventors: Jennifer R. Cochran, Karl Dane Wittrup